# Treatment of Lambert-Eaton Syndrome With 3,4 DAP

> **NCT00704925** · — · NO_LONGER_AVAILABLE · sponsor: **David P. Richman, MD**

## Conditions studied

- Lambert Eaton Myasthenic Syndrome

## Interventions

- **DRUG:** 3, 4 DAP

## Key facts

- **NCT ID:** NCT00704925
- **Lead sponsor:** David P. Richman, MD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2019-10-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00704925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00704925, "Treatment of Lambert-Eaton Syndrome With 3,4 DAP". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00704925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*